- Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study
-
Kim JM, Lee JA, Cho IS, Ihm CH
- KMID: 2083544
- Korean J Hematol.
- 2010 Jun;45(2):115-119.
- doi: 10.5045/kjh.2010.45.2.115
BACKGROUND: Syndecan-1 is a heparan sulfate proteoglycan expressed on plasma cells, especially myeloma cells, and can exist in serum as soluble syndecan-1 after shedding from the cell surface. Soluble syndecan-1... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemical Study for Syndecan-1 and Beta-catenin Expression in Basal Cell Carcinoma
-
Kim HR, Kim MS, Na CH, Shin BS
- KMID: 2301588
- Korean J Dermatol.
- 2012 Aug;50(8):673-678.
BACKGROUND: Syndecan-1 and beta-catenin are cell adhesion molecules, which are expressed primarily on the surface of adult epithelial cells. The expressions of them have been appeared to be inversely correlated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Correlation of Syndecan-1 Expression and Pathologic Risk Factors in Endometrial Carcinoma
-
Kwon JH, Ryu HS, Choi DS, Min CK, Han JH, Chang HJ, Chang KH, Lee JP
- KMID: 2244913
- Korean J Gynecol Oncol Colposc.
- 2004 Jun;15(2):100-106.
OBJECTIVE: Syndecan-1 is transmembrane heparin sulfate proteoglycan that is involved in cell-cell adhesion, organization of cell-matrix adhesion and regulation of growth factor signaling. We tried to evaluate correlation between syndecan-1... -
- CITED
-
- Close
- SHARE
-
- Close
- The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma
-
Kim H, Choi DS, Chang SJ, Han JH, Min CK, Chang KH, Ryu HS
- KMID: 2173513
- J Gynecol Oncol.
- 2010 Mar;21(1):50-55.
- doi: 10.3802/jgo.2010.21.1.50
OBJECTIVE: Aberrant expression of the cell surface proteoglycan, syndecan-1, is found in many malignancies. The current study describes the immunohistochemical study of syndecan-1 expression in normal, hyperplastic, and malignant endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemical Study for the Syndecan-1, E-cadher in and Beta-catenin Expressions in Epidermal Tumors
-
Shin BS, Choi KC, Kim HR, Kim MS
- KMID: 2247585
- Korean J Dermatol.
- 2011 Apr;49(4):309-317.
BACKGROUND: Syndecan-1, E-cadherin and beta-catenin are cell adhesion molecules that are primarily expressed on the surface of adult epithelial cells. The expressions of them appear to be inversely correlated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations
-
Sharma M, Tyagi S, Tripathi P, Seth T
- KMID: 2429319
- Blood Res.
- 2018 Sep;53(3):205-209.
- doi: 10.5045/br.2018.53.3.205
BACKGROUND: Syndecan-1 (sCD138) has recently been suggested to predict the clinical course of early-stage chronic lymphocytic leukemia (CLL), but few studies have been reported. This study assessed the role of... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of syndecan-1 expression in cervical cancers
-
Kim YI, Lee A, Lee BH, Kim SY
- KMID: 2055703
- J Gynecol Oncol.
- 2011 Sep;22(3):161-167.
- doi: 10.3802/jgo.2011.22.3.161
OBJECTIVE: Syndecans are reported to have variable expression in several solid tumors and blood cancers. The cause provoking altered expression of syndecans is not known to date. We studied copy... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Evaluation of Nodal Diffuse Large B Cell Lymphoma by Immunohistochemical Profiles with Emphasis on CD138 Expression as a Poor Prognostic Factor
-
Oh YH, Park CK
- KMID: 1778418
- J Korean Med Sci.
- 2006 Jun;21(3):397-405.
- doi: 10.3346/jkms.2006.21.3.397
Recently diffuse large B cell lymphoma (DLBCLs) was reported to be subdivided into germinal center B-cell-like (GCB) and activated B-cell-like (ABC) subgroups by using cDNA microarray and immunohistochemical markers. Tissue... -
- CITED
-
- Close
- SHARE
-
- Close
